Rigel Pharmaceuticals | RIGL - Market Capitalization


Rigel Pharmaceuticals reported $8.45B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 128M 21M Mar/2026
Amgen USD 195.44B 5.55B Jun/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Celldex Therapeutics USD 2.92B 809M Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
MacroGenics USD 184M 82M Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026